» Articles » PMID: 39234437

Proposed Mechanisms for the Relationship Between Periodontal Diseases and the Severity of Covid-19: Common Pathogens, Inflammatory Mediators, and Risk Factors

Overview
Journal Adv Biomed Res
Date 2024 Sep 5
PMID 39234437
Authors
Affiliations
Soon will be listed here.
Abstract

Periodontal disease (PD) is a chronic inflammatory disease with some cytokine involvement, associated with several risk factors such as diabetes, obesity, etc., Corona Virus Disease 2019 (COVID-19), a new viral infection, also appears to be related to cytokine storm and similar risk factors. In this review, we intend to evaluate the possible relationship between PD and COVID-19. For data collection, English literature was searched in databases including PubMed and Google Scholar. The keywords searched were COVID-19, SARS-CoV-2, PD, respiratory Epidemiological studies indicated that oral pathogens are related to acute and chronic lung disease, and dental plaque is a likely reservoir for respiratory pathogens. SARS-CoV-2 may be released from infected periodontal cells into periodontal pockets. Several studies showed that the serum levels of interleukins (IL)-1, 6, 17, etc., increase in most patients with severe COVID-19. C-reactive protein (CRP) and endothelin 1(ET-1) may also be related to COVID-19 progression, and these mediators also increase in periodontitis. Due to studies, diabetes mellitus (DM), obesity, aging, and male sex are the most important risk factors common between PDs and COVID-19 and may affect treatment outcomes and prognosis. PD seems to play a significant role in exacerbating COVID-19 and even affects the mortality rate of disease.

References
1.
Tukiainen T, Villani A, Yen A, Rivas M, Marshall J, Satija R . Landscape of X chromosome inactivation across human tissues. Nature. 2017; 550(7675):244-248. PMC: 5685192. DOI: 10.1038/nature24265. View

2.
Pacha O, Sallman M, Evans S . COVID-19: a case for inhibiting IL-17?. Nat Rev Immunol. 2020; 20(6):345-346. PMC: 7194244. DOI: 10.1038/s41577-020-0328-z. View

3.
Sunandhakumari V, Sadasivan A, Koshi E, Krishna A, Alim A, Sebastian A . Effect of NonSurgical Periodontal Therapy on Plasma Levels of IL-17 in Chronic Periodontitis Patients with Well Controlled Type-II Diabetes Mellitus-A Clinical Study. Dent J (Basel). 2018; 6(2). PMC: 6023374. DOI: 10.3390/dj6020019. View

4.
Wang J, Yang D, Li C, Shang S, Xiang J . Expression of extracellular matrix metalloproteinase inducer glycosylation and caveolin-1 in healthy and inflamed human gingiva. J Periodontal Res. 2013; 49(2):197-204. DOI: 10.1111/jre.12095. View

5.
Ulhaq Z, Soraya G . Interleukin-6 as a potential biomarker of COVID-19 progression. Med Mal Infect. 2020; 50(4):382-383. PMC: 7129451. DOI: 10.1016/j.medmal.2020.04.002. View